Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab for treatment of biliary atresia
ChiCTR2100046985Phase 4Recruiting
- Sponsor
- Guangzhou Women and Children Medical Center
- Start
- Jun 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of belimumab in biliary atresia (2 arms), sponsored by Guangzhou Women and Children Medical Center. Primary endpoints: Liver function indexes, Lymphocytes count and 2 more. Started Jun 2021; status: recruiting.
02
Drugs
belimumab
03
Conditions
biliary atresia
Beyond the preview
Go deeper on ChiCTR2100046985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046985.